1.
Advances in drug resistance of imatinib mesylate
甲磺酸伊马替尼耐药机制及其逆转研究进展
2.
The Study on the Mechanism of the Gastrointestinal Stromal Tumor Patients with Acquired Resistance to Imatinib Therapy
甲磺酸伊马替尼治疗胃肠道间质瘤与耐药机制的研究
3.
The Effect of Arsenic Trioxide on Imatinib-Resistant Cell Lines K562R and KBM5R
三氧化二砷对伊马替尼耐药细胞株K562R和KBM5R作用机制的研究
4.
Detection of the BCR-ABL Fusion Gene Levels in Chronic Myeloid Leukemia Patients by Real-time Quantitative RT-PCR and Mutation Analysis in the Imatinib Resistant Patients
慢性髓细胞白血病患者bcr/abl的定量检测及伊马替尼耐药患者基因突变分析
5.
Imatinib mesylate inhibits bleomycin-induced pulmonary fibrosis in mice:the mechanism
甲磺酸伊马替尼抑制博莱霉素诱导小鼠肺纤维化的作用机制
6.
The Anti-tumoral Effect of Curcumin Combined with Imatinib on Chronic Myelogenous Leukemia Cell Lines in Vitro;
姜黄素与伊马替尼体外协同抗慢性粒细胞白血病的分子机制研究
7.
The Study on the Mechanism of Apoptosis by Bortezomib and Imatinib in K562 Cells
蛋白酶体抑制剂硼替佐米联合伊马替尼诱导K562细胞凋亡机制的研究
8.
Lapatinib in Combination with Bortezomib Inhibits Breast Cancer Cells Growth and the Activity of Bortezomib to Lapatinib-resistant Breast Cancer Cell
拉帕替尼联合硼替佐米抑制乳腺癌细胞生长及硼替佐米对拉帕替尼耐药细胞的活性的研究
9.
The Establishment of Bortezomib Resistant Myeloma Cell Line and Study of Its Drug Resistance Mechanism
硼替佐米耐药骨髓瘤细胞株的建立及其耐药机制研究
10.
Effect of proteasome inhibitor combined with imatinib on expression of livin mRNA in K562 cells
蛋白酶体抑制剂联合伊马替尼对K562细胞livin基因表达的影响
11.
Atrioventricular block Ⅲ caused by imatinib mesylate
甲磺酸伊马替尼致三度房室传导阻滞
12.
Research on the resistance mechanism of Aspergillus fumigatus to itraconazole
烟曲霉对伊曲康唑耐药机制的研究现况
13.
Experimental Study of Multidrug-resistance Leukemia Mechanism Reversed by Proteasome Inhibitor Bortezomib;
蛋白酶体抑制剂硼替佐米逆转白血病多药耐药机制的实验研究
14.
Metabolite identification of a novel antineoplastic of tyrosine kinase inhibitor,flumatinib,in chronic myelocytic leukemia patients
酪氨酸激酶抑制剂抗肿瘤新药氟马替尼在人体内的代谢产物研究
15.
Clinical Effect of Imatinib on Gastrointestinal Stromal Tumors;
伊马替尼治疗胃肠道间质瘤的临床研究
16.
Efficacy and safety evaluation of imatinib in treatment of patients with chronic myeloid leukemia
伊马替尼治疗慢性粒细胞白血病疗效分析
17.
The Establishment of Proteasome Inhibitor Bortezomib Resistant Leukemia Cell Lines and Study on Its Drug Resistance Mechanism;
蛋白酶体抑制剂硼替唑米耐药白血病细胞系的建立及其耐药机制研究
18.
Mechanisms and Reversal of Resistance to Alkylating Agent Melphalan (Mel);
烷化剂马法兰的耐药机制及逆转途径的研究